1. Home
  2. ASIC vs MLTX Comparison

ASIC vs MLTX Comparison

Compare ASIC & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ategrity Specialty Insurance Company Holdings

ASIC

Ategrity Specialty Insurance Company Holdings

SELL

Current Price

$24.36

Market Cap

1.3B

Sector

Finance

ML Signal

SELL

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

SELL

Current Price

$11.76

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ASIC
MLTX
Founded
2018
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
ASIC
MLTX
Price
$24.36
$11.76
Analyst Decision
Buy
Buy
Analyst Count
5
16
Target Price
$28.40
★ $30.29
AVG Volume (30 Days)
73.7K
★ 1.5M
Earning Date
10-21-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.44
N/A
EPS
★ 1.47
N/A
Revenue
★ $424,339,000.00
N/A
Revenue This Year
$24.89
N/A
Revenue Next Year
$22.34
N/A
P/E Ratio
$16.69
★ N/A
Revenue Growth
★ 23.41
N/A
52 Week Low
$16.73
$9.46
52 Week High
$29.00
$23.29

Technical Indicators

Market Signals
Indicator
ASIC
MLTX
Relative Strength Index (RSI) 45.26 48.11
Support Level $23.36 $9.73
Resistance Level $25.62 $13.51
Average True Range (ATR) 0.84 0.84
MACD 0.08 0.12
Stochastic Oscillator 62.35 33.23

Price Performance

Historical Comparison
ASIC
MLTX

About ASIC Ategrity Specialty Insurance Company Holdings

Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: